Defunct Company
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
223
NCT05325775
Dose-ranging, PK, Safety, Efficacy Study of Osanetant in Patients With Moderate/Severe VMS Associated With Menopause
Phase: Phase 1/2
Role: Lead Sponsor
Start: Mar 30, 2022
Completion: Mar 4, 2023
NCT05432466
Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome
Phase: Phase 3
Start: Nov 7, 2022
Completion: Apr 1, 2029
NCT06069375
Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)
Phase: Phase 2
Role: Collaborator
Start: Apr 1, 2024
Completion: Dec 31, 2026